DeepDyve gives its users five minutes of free access

William Park
William Park

Five minutes may not seem like a lot of time, but research shows it's all a scientist needs to know if a published study meets his or her needs. This finding, says William Park, CEO of publisher middleman DeepDyve, prompted the firm to expand its content-streaming service to let users look at articles in their entirety for five minutes, after which they can choose from a menu of article “rental” options, including streaming—but not downloading—or buying it from DeepDyve or the publisher.

The five-minute Freemium approach, which became a full offering on June 5, is an alternative to the site's two-week access teaser, which requires potential users to submit an email address and a credit card before gaining full streaming reading privileges.

Park said the freedom to preview, rent and buy articles with a relatively low cost is critical for researchers. He also said users tend to come from expected sectors like biotech and engineering as well as finance, “as opposed to liberal arts.”

Promoting DeepDyve has been a muted effort for the company that started as a business-to-business entity and then moved into the rental information space. Park says the company gets a lot of traffic from search engine optimization and Google. The publishers also send traffic DeepDyve's way—providing a Freemium preview link on pages that feature the abstracts.

Park said he expects to tap into social-media promotion this year, and will go beyond attending publisher-centric conferences to include industry ones as well.
You must be a registered member of MMM to post a comment.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.